Clinical Trials in Nashville

Showing 1001-1020 of 17,403 trials

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

NCT05421741

This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.

Osteomyelitis TibiaTibial FracturesOpen Tibia Fracture

Wake Forest University Health Sciences484 participantsStarted May 2023

Gainesville, Florida, United States • Temple Terrace, Florida, United States • Macon, Georgia, United States +11 more locations

RECRUITINGPhase 1/2< 1 mile

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

NCT05098132

This is a phase 1/2, multicenter, open-label study. The phase 1 portion is a dose escalation and expansion study of STK-012 as monotherapy and in combination therapy in patients with selected advanced solid tumors. The phase 2 portion is a randomized study of STK-012 in combination with standard of care (SoC) pembrolizumab, pemetrexed, and carboplatin versus SoC, in patients with first line, PD-L1 negative, non-squamous, non-small cell lung cancer.

Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more

Synthekine364 participantsStarted Jan 2022

Tucson, Arizona, United States • Beverly Hills, California, United States • Fullerton, California, United States +24 more locations

Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Find Trials by Condition in Nashville

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

A Study of DF6002 Alone and in Combination With Nivolumab

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Single Arm Romiplostim to Prevent CIT

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

Venclose digiRF System Post Market Study

Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa